Eclipsys skips into black in Q2

Eclipsys logged a solid second quarter, ended June 30, with quarterly revenues of $134.4 million, compared to $129.8 million for the second quarter of 2009.

On a GAAP [generally accepted accounting principles] basis, net income for the second quarter of 2010 was $1.6 million, compared with net loss of $4.1 million in the second quarter of 2009, according to the Atlanta-based company.

For the six months that ended June 30, new business bookings were $259.4 million, as new and existing customers made investment decisions to meet the meaningful use criteria of the American Reinvestment and Recovery Act. The company said it defines new business bookings as the total amount of all new contracts signed, excluding renewal contracts.

Eclipsys ended the quarter with $143.3 million of cash and $37.3 million in long-term investments.

Around the web

The American College of Cardiology has sent a letter to HHS Secretary Robert F. Kennedy Jr. that outlines some of the organization’s central priorities and concerns. 

One product is being pulled from the market, and the other is receiving updated instructions for use.

If the Trump administration continues taking a laissez-faire stance toward AI—including AI used in healthcare—why not let the states go it alone on regulating the technology?